July 13 (Reuters) - Vitrolife AB VITR.ST :
* INTERIM REPORT JANUARY - JUNE 2020: EXTENSIVE IMPACT OF
COVID-19
* Q2 SALES SEK 209 MILLION VERSUS SEK 381 MILLION YEAR AGO
* SALES WERE NEGATIVELY IMPACTED BY A DECREASE IN DEMAND DUE
TO
COVID-19
* DEMAND WAS SIGNIFICANTLY HIGHER AT END OF QUARTER COMPARED
TO
BEGINNING OF QUARTER.
* Q2 EBITDA SEK 40 MILLION VERSUS SEK 146 MILLION YEAR AGO
* Q2 NET INCOME SEK 12 MILLION VERSUS SEK 95 MILLION YEAR
AGO
Source text for Eikon: ID:nWkrmPgr2
Further company coverage: VITR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587785110;))